Aptose Biosciences Inc.
Aryl imidazoles for treatment of cancer
Last updated:
Abstract:
The present invention relates to a method of preventing, reducing, or treating cancer in a subject, comprising administering a therapeutically effective amount of ##STR00001## or a pharmaceutically acceptable salt, free base, hydrate, complex, or chelate (including metal chelates, such as iron, zinc and others) thereof to the subject, wherein the subject has a mutation in a DNA repair gene.
Status:
Grant
Type:
Utility
Filling date:
30 Oct 2018
Issue date:
19 Oct 2021